Accounts Receivable, after Allowance for Credit Loss, Current in USD of MARIZYME, INC. from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
MARIZYME, INC. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and change rate from Q4 2010 to Q3 2024.
  • MARIZYME, INC. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 30 Sep 2024 was $2,000, a 95% decline year-over-year.
Source SEC data
View on sec.gov
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

MARIZYME, INC. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $2,000 -$41,218 -95% 30 Sep 2024 10-Q 05 Mar 2025 2024 Q3
Q4 2023 $60,284 -$27,517 -31% 31 Dec 2023 10-Q 05 Mar 2025 2024 Q3
Q3 2023 $43,218 -$11,007 -20% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $72,975 +$19,892 +37% 30 Jun 2023 10-Q 18 Aug 2023 2023 Q2
Q1 2023 $78,169 +$69,519 +804% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $87,801 +$79,151 +915% 31 Dec 2022 10-K/A 06 Feb 2025 2023 FY
Q3 2022 $54,225 -$42,066 -44% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $53,083 -$66,188 -55% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $8,650 -$27,133 -76% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $8,650 -$31,935 -79% 31 Dec 2021 10-K 24 Mar 2023 2022 FY
Q3 2021 $96,291 +$3,281 +3.5% 30 Sep 2021 10-Q 22 Nov 2021 2021 Q3
Q2 2021 $119,271 30 Jun 2021 10-Q/A 22 Nov 2021 2021 Q2
Q1 2021 $35,783 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $40,585 +$40,585 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $93,010 30 Sep 2020 10-Q/A 24 Nov 2020 2020 Q3
Q4 2019 $0 31 Dec 2019 10-Q/A 24 Nov 2020 2020 Q3
Q3 2018 $0 -$292,999 -100% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q4 2017 $130,766 +$114,766 +717% 31 Dec 2017 10-Q 14 Nov 2018 2018 Q3
Q3 2017 $292,999 30 Sep 2017 10-K/A 27 Jun 2018 2017 FY
Q2 2017 $282,914 30 Jun 2017 10-K/A 27 Jun 2018 2017 FY
Q1 2017 $319,025 31 Mar 2017 10-K/A 27 Jun 2018 2017 FY
Q4 2016 $16,000 -$1,023 -6% 31 Dec 2016 10-K/A 27 Jun 2018 2017 FY
Q4 2015 $17,023 $0 0% 31 Dec 2015 10-K/A 27 Jun 2018 2017 FY
Q4 2014 $17,023 -$349,738 -95% 31 Dec 2014 10-K/A 27 Jun 2018 2017 FY
Q4 2013 $366,761 +$95,053 +35% 31 Dec 2013 10-K/A 27 Jun 2018 2017 FY
Q3 2013 $3,528,260 -$2,215 -0.06% 30 Sep 2013 10-Q/A 15 May 2014 2013 Q3
Q2 2013 $3,666,291 -$4,562,366 -55% 30 Jun 2013 10-Q/A 22 Aug 2013 2013 Q2
Q1 2013 $3,205,807 -$1,731,080 -35% 31 Mar 2013 10-Q/A 15 Aug 2013 2013 Q1
Q4 2012 $271,708 -$4,578,799 -94% 31 Dec 2012 10-K/A 27 Jun 2018 2017 FY
Q3 2012 $3,530,475 -$1,013,548 -22% 30 Sep 2012 10-Q/A 17 Dec 2012 2012 Q3
Q2 2012 $8,228,657 +$2,948,323 +56% 30 Jun 2012 10-Q/A 13 Sep 2012 2012 Q1
Q1 2012 $4,936,887 -$761,434 -13% 31 Mar 2012 10-Q/A 13 Sep 2012 2012 Q1
Q4 2011 $4,850,507 -$861,650 -15% 31 Dec 2011 10-K/A 08 May 2014 2012 FY
Q3 2011 $4,544,023 30 Sep 2011 10-Q/A 19 Jul 2013 2011 Q3
Q2 2011 $5,280,334 30 Jun 2011 10-Q/A 18 Jul 2013 2011 Q2
Q1 2011 $5,698,321 31 Mar 2011 10-K 16 Jul 2012 2011 FY
Q4 2010 $5,712,157 31 Dec 2010 10-K/A 31 Mar 2014 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.